Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retroviruses02:33

Retroviruses

12.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.1K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dried Blood Spot Testing in Confirmed Congenital Cytomegalovirus Discovered by Expanded Targeted Testing.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Reverse Transcriptase Activity with CRISPR (REACTR) Assay for Rapid and User-Friendly Therapeutic Drug Monitoring in Cytomegalovirus Care.

ACS infectious diseases·2026
Same author

Pharmacokinetics and Pharmacodynamics of (Val)Ganciclovir in Infants with Congenital Cytomegalovirus.

medRxiv : the preprint server for health sciences·2026
Same author

Unpacking cerumen impaction: a systematic review of clinical practice guidelines to support the development of the world health organization package of ear and hearing care interventions.

BMC primary care·2026
Same author

Facial Nerve Grafting after Malignant Nerve Sacrifice: Functional Outcomes With and Without Adjuvant Radiation.

Facial plastic surgery & aesthetic medicine·2026
Same author

Medical Education Beyond Beirut: A Qualitative Study of Rural Training in Lebanon.

Cureus·2026

Related Experiment Video

Updated: May 3, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.3K

Update on an Expanded Targeted Early Cytomegalovirus Testing Program From a Large Health Care System.

Peter Kfoury1, Megna D Reddy1, Albert H Park1,2

  • 1Department of Otolaryngology - Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, UT.

Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology
|January 5, 2026
PubMed
Summary

An expanded screening program effectively detected congenital cytomegalovirus (cCMV) in Utah newborns. Early detection enabled timely interventions for affected infants, improving outcomes.

Keywords:
CMVCongenitalCytomegalovirusHearing lossInfectionNewbornScreeningSensorineuralTORCH infection

More Related Videos

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
08:08

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

Published on: July 9, 2014

16.3K
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.8K

Related Experiment Videos

Last Updated: May 3, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.3K
qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
08:08

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

Published on: July 9, 2014

16.3K
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.8K

Area of Science:

  • Neonatal screening
  • Public health
  • Infectious disease surveillance

Background:

  • Congenital cytomegalovirus (cCMV) is a leading infectious cause of non-genetic hearing loss in newborns.
  • Early detection and intervention are crucial for mitigating long-term neurodevelopmental consequences.

Purpose of the Study:

  • To evaluate the effectiveness of an expanded targeted screening program for cCMV detection in a large healthcare system.
  • To determine the prevalence of cCMV and associated clinical characteristics in the screened population.

Main Methods:

  • Retrospective cohort study analyzing data from Intermountain Healthcare (IHC) in Utah.
  • Infants born between March 1, 2021, and August 31, 2024, were screened for cCMV within six months of birth.
  • Data collected included screening test orders, live births, confirmed cCMV cases, and audiological outcomes.

Main Results:

  • Over 3.5 years, 8598 cCMV screening tests were performed among 93,529 live births.
  • The program identified 32 confirmed cCMV cases, resulting in an estimated prevalence of 34 cases per 100,000 live births.
  • Hearing loss was diagnosed in 28% (9/32) of cCMV-positive infants, with 8 children receiving hearing aids or cochlear implants.

Conclusions:

  • The expanded targeted cCMV testing program is effective in identifying newborns with cCMV.
  • Early detection facilitates timely intervention, highlighting the program's feasibility and potential for improved infant outcomes.
  • This approach offers opportunities for enhanced early intervention and treatment strategies for cCMV.